Bevacizumab (avastin) and imatinib mesylate (gleevec)    (DrugBank: Bevacizumab, Imatinib)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
87肺静脈閉塞症/肺毛細血管腫症1

87. 肺静脈閉塞症/肺毛細血管腫症 [臨床試験数:3,薬物数:4(DrugBank:3),標的遺伝子数:4,標的パスウェイ数:43
Searched query = "Pulmonary veno-occlusive disease", "Pulmonary capillary hemangiomatosis", "PVOD", "PCH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 3 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00891527
(ClinicalTrials.gov)
October 200830/4/2009Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein StenosisAdjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein StenosisPulmonary Veno Occlusive DiseaseDrug: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)Boston Children's HospitalNULLCompletedN/AN/AAll50Phase 1/Phase 2United States